S3518 (2023-24 session)
NY State bill
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
- Title
- Enacts the manufacturer disclosure and transparency act
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- In Assembly Committee
- Latest action date
- 2024-01-30
- In committee
- Consumer Affairs And Protection
- Introduced
- 2023-01-31
- Same as
- A895
- Law section
- General Business Law
Sponsors
- Nathalia Fernandez State Senator, District 34
Co-sponsors
- Joseph P. Addabbo Jr. State Senator, District 15
Heard in committee
- Consumer Affairs and Protection NY State Assembly committee
- Consumer Protection NY State Senate committee
Same as
- A895 (2023-24 session) NY State bill
Committee meetings
Committee meetings that took this bill up, from the Senate's published agendas. The Assembly does not publish its committee agendas in machine-readable form, so an Assembly committee's consideration of a bill is not on this list.
- Consumer Protection, 2024-01-09 First reading